M. Thomas (Munster, Germany), P. Stockton (Liverpool, United Kingdom)
TNM and survival in small cell lung cancer: results of a population-based study
T. Blankenburg, H. Neef, J. Haerting, P. Schmidt, W. Schuette (Halle, Germany)
|  |
Impact of poor performance status of the treatment of small cell lung cancer
P. A. Stockton, J. Hendry, M. J. Walshaw, E. Marshall (Liverpool, Prescot, Wirral, United Kingdom)
| |
Stage, therapy and surviving of small cell lung cancer: analysis of a nonselected patient collective 1993-1997
W. R. Guschall, R. Floegel, G. Liebetrau, I. Dittrich (Lostau, Germany)
| |
Surgical management of patients with small cell lung cancer
P. A. Stockton, R. D. Page, J. Gosney, M. J. Walshaw, E. Marshall (Liverpool, United Kingdom)
| |
Multicentre phase II trial of paclitaxel, cisplatin, and etoposide with concurrent radiation for limited stage small cell lung cancer
R. M. Bremnes, S. Sundstroem, J. Vilsvik, U. Aaseboe (Tromsoe, Trondheim, Norway)
| |
Early concurrent normo- and hyperfractionated chemoradiotherapy in limited small cell lung cancer (LSCLC): a nonrandomized comparison of 22 consecutive patients
Z. Skacel, M. Marel, J. Prausova, K. Hovorkova, R. Pipkova, K. Kosatova, L. Melinova, B. Stastny (Prague, Czech Republic)
| |
Small cell lung cancer: local control with an alternate chemoradiation schedule
L. Gaspar, E. Teixeira, R. Sotto-Mayor, M. Ortiz (Lisboa, Portugal)
| |
Sequential monochemotherapy: vepesid (VP16) and carboplatin (CBDCA) in the treatment of elderly patients with small cell lung cancer (SCLC)
M. Tondini, P. A. Chini, D. Corbellini, A. Merizzi, P. Mercurio, L. Salada, F. Speciale, D. Sereni (Esine, Sondalo, Italy)
| |
Second-line treatment patients at relapse of disseminated small cell lung cancer
B. Mehic, Z. Dizdarevic, H. Zutic (Sarajevo, Bosnia)
| |
Superior vena cava syndrome induced by bronchogenic carcinoma: the use of radiotherapy, chemotherapy and Gianturco self-expanding stent
M. H. Rancic, P. A. Bosnjakovic, T. A. Pejcic, I. J. Stankovic, D. V. Djordjevic, D. S. Zivkovic, L. M. Ristic, S. M. Rancic, M. B. Cekic (Nis, Yugoslavia)
| |
Myocardial infarction (MI) as a cause of death in patients treated for small cell lung cancer (SCLC)
P. Remiszewski, J. Slodkowska, B. Roszkowska, E. Decker, M. Marzinek, E. Rowiñska-Zakrzewska (Warsaw, Poland)
| |
Detection of antibodies against recoverin in the serum of patients with small cell lung cancer in the absence of cancer-associated retinopathy
O. N. Shifrina, A. V. Bazhin, M. S. Savchenko, A. G. Chuchalin, P. P. Philippov (Moscow, Russia)
| |